Charlotte Ling

Biography

Charlotte Ling is a Professor at Lund University and a principle investigator of the Epigenetics and Diabetes Unit at Lund University Diabetes Centre (LUDC), Sweden. She obtained her PhD in Endocrinology at University of Gothenburg, Sweden in 2002. After a postdoc at Lund University, where she studied genetics of Type 2 diabetes, she dedicated her research to the study of epigenetic mechanisms causing Type 2 diabetes and metabolic disease. Her research group has pioneered the field of epigenetics in Type 2 diabetes. They have made several groundbreaking discoveries such as genome-wide epigenetic modifications in pancreatic islets, skeletal muscle, adipose tissue and the liver from patients with Type 2 diabetes compared with non-diabetic control subjects.

Research Interest

Ling’s research group has also shown that genetic and non-genetic factors such as SNPs, exercise, diet, obesity and age alter the genome-wide epigenetic pattern in human primary tissues for Type 2 diabetes. Dr. Ling is frequently invited to write review papers and book chapters and to give lectures (e.g. ADA, IDF, Keystone and Endocrine Society) on the topic ‘Epigenetics in Type 2 Diabetes’. Dr. Ling has been awarded research grants from numerous national and international foundations including the Swedish Research Council, Novo Nordisk Excellence award, EFSD-Lilly, Söderberg’s foundation and the European Commission (H2020 and ERC).